Docetaxel, cisplatin, and fluorouracil in gastric cancer: Does the punishment fit the crime?

被引：50

作者：

Ilson, David H. ^{[1
]}

机构：

[1] Mem Sloan Kettering Canc Ctr, New York, NY 10021 USA

来源：

JOURNAL OF CLINICAL ONCOLOGY | 2007年 / 25卷 / 22期

关键词：

D O I：

10.1200/JCO.2006.10.2210

中图分类号：

R73 [肿瘤学];

学科分类号：

100214 ;

摘要：

引用

收藏

页码：3188 / 3190

页数：3

相关论文

共 16 条

[1] CPT-11 plus cisplatin in patients with advanced, untreated gastric or gastroesophageal junction carcinoma - Results of a Phase II study [J].

Ajani, JA ;

Baker, J ;

Pisters, PWT ;

Ho, L ;

Mansfield, PF ;

Feig, BW ;

Charnsangavej, C .

CANCER, 2002, 94 (03) :641-646

[2] Multicenter phase II trial of S-1 plus cisplatin in patients with untreated advanced gastric or gastroesophageal junction adenocarcinoma [J].

Ajani, JA ;

Lec, FC ;

Singh, DA ;

Haller, DG ;

Lenz, HJ ;

Benson, AB ;

Yanagilhara, R ;

Phan, AT ;

Yao, JC ;

Strumberg, D .

JOURNAL OF CLINICAL ONCOLOGY, 2006, 24 (04) :663-667

[3] Phase II multi-institutional randomized trial of docetaxel plus cisplatin with or without fluorouracil in patients with untreated, advanced gastric, or gastroesophageal adenocarcinoma [J].

Ajani, JA ;

Fodor, MB ;

Tjulandin, SA ;

Moiseyenko, VM ;

Chao, Y ;

Filho, SC ;

Cabral, S ;

Majlis, A ;

Assadourian, S ;

Van Cutsem, E .

JOURNAL OF CLINICAL ONCOLOGY, 2005, 23 (24) :5660-5667

[4] Quality of life with docetaxel plus cisplatin and fluorouracil compared with cisplatin and fluorouracil from a phase III trial for advanced gastric or gastroesophageal adenocarcinoma: The V-325 study group [J].

Ajani, Jaffer A. ;

Moiseyenko, Vladimir M. ;

Tjulandin, Sergei ;

Majlis, Alejandro ;

Constenla, Manuel ;

Boni, Corrado ;

Rodrigues, Adriano ;

Fodor, Miguel ;

Chao, Yee ;

Voznyi, Edouard ;

Awad, Lucile ;

Van Cutsem, Eric .

JOURNAL OF CLINICAL ONCOLOGY, 2007, 25 (22) :3210-3216

[5] Clinical benefit with docetaxel plus fluorouracil and cisplatin compared with cisplatin and fluorouracil in a phase III trial of advanced gastric or gastroesophageal cancer adenocarcinoma: The V-325 study group [J].

Ajani, Jaffer A. ;

Moiseyenko, Vladimir M. ;

Tjulandin, Sergei ;

Majlis, Alejandro ;

Constenla, Manuel ;

Boni, Corrado ;

Rodrigues, Adriano ;

Fodor, Miguel ;

Chao, Yee ;

Voznyi, Edouard ;

Marabotti, Cindy ;

Van Cutsem, Eric .

JOURNAL OF CLINICAL ONCOLOGY, 2007, 25 (22) :3205-3209

[6]

ALBATRAN S, 2006, J CLIN ONCOL, V24

[7]

Cunningham D, 2006, J CLIN ONCOL, V24, pLBA4017

[8]

DANK M, 2005, J CLIN ONCOL, V23

[9]

KANG Y, 2006, J CLIN ONCOL, V24

[10] Prospective randomized trial comparing mitomycin, cisplatin, and protracted venous-infusion fluorouracil (PV1 5-FU) with epirubicin, cisplatin, and PV15-FU in advanced esophagogastric cancer [J].

Ross, P ;

Nicolson, M ;

Cunningham, D ;

Valle, J ;

Seymour, M ;

Harper, P ;

Price, T ;

Anderson, H ;

Iveson, T ;

Hickish, T ;

Lofts, F ;

Norman, A .

JOURNAL OF CLINICAL ONCOLOGY, 2002, 20 (08) :1996-2004